Related Experiment Video
Updated: Oct 20, 2025

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.9K
Clustering of Brain Tumor Based on Analysis of MRI Images Using Robust Principal Component Analysis (ROBPCA)
Ali Hamzenejad1, Saeid Jafarzadeh Ghoushchi2, Vahid Baradaran1
1Department of Industrial Engineering, Islamic Azad University, Tehran North Branch, Tehran, Iran.
Biomed Research International
|September 10, 2021
Summary
This study introduces an unsupervised robust PCA algorithm for automated brain tumor detection in MRI images. The method accurately identifies tumor locations across various brain diseases, showing high sensitivity and potential for clinical application.
Area of Science:
- Medical Imaging
- Artificial Intelligence
- Neurology
Background:
- Accurate brain tumor detection is crucial for diagnosis and treatment planning.
- Existing methods may require manual intervention or struggle with complex image features.
Purpose of the Study:
- To develop and validate an automated method for brain tumor location detection using unsupervised clustering.
- To assess the efficacy of a robust Principal Component Analysis (PCA) algorithm for segmenting brain MRI images.
Main Methods:
- Unsupervised robust PCA algorithm applied to cluster brain MRI pixels into four leverages.
- Algorithm validated on MRI images from five brain diseases: glioma, Huntington's, meningioma, Pick's, and Alzheimer's.
- Utilized ten images per disease for performance evaluation.
Main Results:
- The algorithm successfully identified tumor locations with high sensitivity, accurately discerning lesions.
- Approximately 2% of data in suboptimal image regions were identified as indicative of tumors.
- The method demonstrated superior performance for glioma images compared to other diseases.
Conclusions:
- The unsupervised robust PCA method shows significant potential for automated brain tumor detection in various neurological conditions.
- The algorithm's ability to accurately locate lesions, as confirmed by ROC curve analysis, supports its clinical utility.
- Further refinement may enhance performance across all tested brain diseases.

